Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-004877
Filing Date
2020-02-18
Accepted
2020-02-18 16:22:54
Documents
1
Period of Report
2020-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4133
  Complete submission text file 0000899243-20-004877.txt   5489
Mailing Address 39 OLD RIDGEBURY RD. SUITE 11 DANBURY CT 06810
Business Address
SCIASCIA THOMAS (Reporting) CIK: 0001229946 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38886 | Film No.: 20625618

Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations